Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
A different scope from Chemical Profiles, which picks out a specific, pre-chosen family of compounds (a phytochemistry-style approach). This section is for full metabolomics: an unbiased sweep of every metabolite detectable in a sample at once, meant to surface biochemical activity and pathway-level behavior that a narrowly targeted compound list would miss. This section provides real matched experimental-metabolomics studies (MetaboLights) and real genome-based metabolic-pathway inference (KEGG) for species with a genome already in this catalog — KEGG rows reflect which pathways a species' own annotated genes place it in, not experimentally measured metabolite presence, stated explicitly on every such row below.
Have data of this kind? How to contribute data →
KEGG: KEGG genome-based metabolic profile (rmp) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (rcu) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (raf) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (rase) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (ray) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
MetaboLights: Original data of bacterial antibiotic resistance lipidomics (View at source ↗)AFDSI-METABPROF-300
MetaboLights: Salmonella Modulates Metabolism during Growth under Conditions that Induce Expression of Virulence Genes (View at source ↗)AFDSI-METABPROF-301
MetaboLights: The impact of slyA on cell metabolism of Salmonella Typhimurium: a joint study of transcriptomics and metabolomics (View at source ↗)AFDSI-METABPROF-302
MetaboLights: Metabolomic analysis of the mechanism of action of yerba mate extract on Salmonella Typhimurium (View at source ↗)AFDSI-METABPROF-303
MetaboLights: L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS positive mode) (View at source ↗)AFDSI-METABPROF-304
MetaboLights: L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS negative mode) (View at source ↗)AFDSI-METABPROF-458
MetaboLights: L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS positive mode) (View at source ↗)AFDSI-METABPROF-305
MetaboLights: L-leucine increases the sensitivity of drug-resistant Salmonella to sarafloxacin by stimulating central carbon metabolism and increasing intracellular reactive oxygen species level (LC-MS negative mode) (View at source ↗)AFDSI-METABPROF-306
MetaboLights: A pathogen-specific isotope tracing approach reveals metabolic activities and fluxes of intracellular Salmonella (View at source ↗)AFDSI-METABPROF-307
KEGG: KEGG genome-based metabolic profile (seeb) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (senb) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence
KEGG: KEGG genome-based metabolic profile (sec) (View at source ↗) — Genome-based pathway inference (KEGG) — reflects which metabolic pathways this species' annotated genes place it in, not experimentally measured metabolite presence